PDL-1 expression was also significantly associated with poor overall survival in ChS and osteosarcoma [151], and it was significantly related to a younger age (<30 years), a larger tumor size (>10 cm), an advanced tumor grade, and an earlier recurrence. This evidence concerns the gene CD274 and neoplasm.